Publications by authors named "Chengcheng Meng"

Claim this Profile
H
Highly efficient and safe sterilization of reusable medical devices and implants by slightly acidic electrolyzed water.
Yan Zhang, Chengcheng Meng, Wenze Ma, Lin Xie, Yi Zhang

Biofouling· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy.
Wei Ni, Swati Garg, Basudev Chowdhury, Martin Sattler, Dana Sanchez, Chengcheng Meng

Mol Ther Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDs.
Wei Ni, Swati Garg, Basudev Chowdhury, Martin Sattler, Dana Sanchez, Chengcheng Meng

Mol Ther Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Highly Potent and Selective HDAC8 Degrader: Advancing the Functional Understanding and Therapeutic Potential of HDAC8.
Yufeng Xiao, Nikee Awasthee, Yi Liu, Chengcheng Meng, Michael Y He

J Med Chem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of bacterial biofilms by a green synthesized artemisinin nano-copper nanomaterial.
Yan Zhang, Xia Hua, Xiaohu Han, Xue Fang, Peng Li, Chengcheng Meng

Metallomics· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDKL3 is a targetable regulator of cell cycle progression in cancers.
Haijiao Zhang, Jiahui Lin, Shaoqin Zheng, Lanjing Ma, Zhongqiu Pang, Chengcheng Meng

J Clin Invest· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple Myeloma.
Basudev Chowdhury, Swati Garg, Wei Ni, Martin Sattler, Dana Sanchez, Chengcheng Meng

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation.
Yufeng Xiao, Seth Hale, Nikee Awasthee, Chengcheng Meng, Xuan Zhang

Cell Chem Biol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DAXX drives de novo lipogenesis and contributes to tumorigenesis.
Iqbal Mahmud, Guimei Tian, Jia Wang, Tarun E Hutchinson, Brandon J Kim, Chengcheng Meng

Nat Commun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-SARS-CoV-2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID-19 therapy.
RuthMabel Boytz, Mikołaj Słabicki, Sita Ramaswamy, J J Patten, Charles Zou, Chengcheng Meng

J Med Virol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma.
Ellen Weisberg, Basudev Chowdhury, Chengcheng Meng, Abigail E Case, Wei Ni

Blood Cancer J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2.
Jing Yang, Ellen L Weisberg, Shuang Qi, Wei Ni, Husheng Mei, Chengcheng Meng

Leukemia· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2.
Jing Yang, Ellen L Weisberg, Xiaoxi Liu, Robert S Magin, Wai Cheung Chan, Chengcheng Meng

Leukemia· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of cell lysis by Fenton oxidation on cryptic growth in sequencing batch reactor (SBR): Implication of reducing sludge source discharge.
Yu Zhang, Chengcheng Meng, Yueling He, Xiaonuan Wang, Gang Xue

Sci Total Environ· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM).
Moshe Lapidot, Abigail E Case, Ellen L Weisberg, Chengcheng Meng, Sarah R Walker

Br J Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variations of forage yield and forage-livestock balance in grasslands over the Tibetan Pla-teau, China.
Xing-Guo Mo, Wen Liu, Cheng-Cheng Meng, Shi Hu, Su-Xia Liu

Ying Yong Sheng Tai Xue Bao· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM).
Moshe Lapidot, Abigail E Case, Dalia Larios, Helen I Gandler, Chengcheng Meng

Cancers (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Evaluation of ERK as a therapeutic target in acute myelogenous leukemia.
Ellen Weisberg, Chengcheng Meng, Abigail Case, Martin Sattler, Hong L Tiv

Leukemia· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residues 315 and 369 in HN Protein Contribute to the Thermostability of Newcastle Disease Virus.
Baoyang Ruan, Xiaorong Zhang, Chengcheng Zhang, Pengyu Du, Chengcheng Meng, Mengjiao Guo

Front Microbiol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing of Kinase Inhibitors for Treatment of COVID-19.
Ellen Weisberg, Alexander Parent, Priscilla L Yang, Martin Sattler, Qingsong Liu, Chengcheng Meng

Pharm Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the deubiquitinase USP10 induces degradation of SYK.
Jing Yang, Chengcheng Meng, Ellen Weisberg, Abigail Case, Ilaria Lamberto

Br J Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the multi-kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia.
Ellen Weisberg, Chengcheng Meng, Abigail E Case, Hong L Tiv, Prafulla C Gokhale

J Cell Mol Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of ERK as a therapeutic target in acute myelogenous leukemia.
Ellen Weisberg, Chengcheng Meng, Abigail Case, Martin Sattler, Hong L Tiv

Leukemia· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive evaluation of the effects of climate change and land use and land cover change variables on runoff and sediment discharge.
Huilan Zhang, Chengcheng Meng, Yujie Wang, Yunqi Wang, Ming Li

Sci Total Environ· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of FLT3 and SYK kinase inhibitors is toxic to leukaemia cells with CBL mutations.
Ellen Weisberg, Chengcheng Meng, Abigail E Case, Hong L Tiv, Prafulla C Gokhale

J Cell Mol Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis